Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/jc.2008-0065PMID 18611974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene expression profiling of childhood adrenocortical tumors.

  2007cited by this paper
• The role of the IGF system in cancer growth and metastasis: overview and recent insights.

  2007influential reference
• Adrenocortical cancer: pathophysiology and clinical management.

  2007cited by this paper
• The Molecular Pathogenesis of Childhood Adrenocortical Tumors

  2007cited by this paper
• Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

  2007cited by this paper
• The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours.

  2006cited by this paper
• Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells.

  2006influential reference
• Emerging treatment strategies for adrenocortical carcinoma: a new hope.

  2006cited by this paper
• Down-Regulation of Insulin-Like Growth Factor I Receptor Activity by NVP-AEW541 Has an Antitumor Effect on Neuroblastoma Cells In vitro and In vivo

  2006cited by this paper
• Adrenocortical Carcinoma: Clinical Update

  2006cited by this paper
• Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients.

  2006cited by this paper
• Deletion mapping of chromosome 17 in benign and malignant adrenocortical tumors associated with the Arg337His mutation of the p53 tumor suppressor protein.

  2005cited by this paper
• Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.

  2005cited by this paper
• Microarray‐based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression

  2005cited by this paper
• Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.

  2005influential reference
• Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy.

  2005cited by this paper
• In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase.

  2004cited by this paper
• Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.

  2004cited by this paper
• Melan A (A103) Is Expressed in Adrenocortical Neoplasms but Not in Renal Cell and Hepatocellular Carcinomas

  2003cited by this paper
• The Insulin-Like Growth Factor (IGF) Family and Breast Cancer

  2003cited by this paper
• Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis.

  2003cited by this paper
• Adrenal Cortical Neoplasms in the Pediatric Population: A Clinicopathologic and Immunophenotypic Analysis of 83 Patients

  2003influential reference
• Insulin-like growth factor receptor-1 as an anti-cancer target: blocking transformation and inducing apoptosis.

  2002cited by this paper
• An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• British Journal of Cancer

  2001cited by this paper
• Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.

  2001cited by this paper
• cfos and cjun antisense oligonucleotides block mitogenesis triggered by fibroblast growth factor-2 and ACTH in mouse Y1 adrenocortical cells.

  2001cited by this paper
• An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

  2001cited by this paper
• An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors.

  2001cited by this paper
• Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line.

  1999cited by this paper
• Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma

  1998cited by this paper
• [Childhood adrenocortical tumors].

  1997cited by this paper
• Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors.

  1997cited by this paper
• Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands.

  1997cited by this paper
• Childhood adrenocortical tumors.

  1997cited by this paper
• Extensive personal experience: adrenocortical tumors.

  1997cited by this paper
• Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene.

  1996cited by this paper
• Clinical, hormonal and pathological findings in a comparative study of adrenocortical neoplasms in childhood and adulthood.

  1995cited by this paper
• Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.

  1994cited by this paper
• Insulin-like growth factor binding proteins in the human adrenal gland

  1993cited by this paper
• Immunoreactivity and receptor expression of insulinlike growth factor I and insulin in human adrenal tumors. An immunohistochemical study of 94 cases.

  1991cited by this paper
• Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis.

  1990influential reference
• Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors

  1984cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Pediatric Adrenocortical Tumors: Molecular Events Leading to Insulin-Like Growth Factor II Gene Overexpression*

  year unknowncited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Postnatal Overexpression of Insulin-Like Growth Factor II in Transgenic Mice Is Associated with Adrenocortical

  year unknowncited by this paper
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method

  year unknowncited by this paper

• Histopathological and Molecular Characteristics of Pediatric Adrenocortical Tumors: where Do we Stand?

  2026cites this paper
• Targeting pediatric adrenocortical carcinoma: Molecular insights and emerging therapeutic strategies.

  2025cites this paper
• Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas

  2025influential citation
• The Cytoskeleton in Adrenal Physiology and Tumours: Functional Roles and Emerging Molecular Targets

  2025cites this paper
• Relationship of obesity, body fat, benign adrenal tumors and the mediating mechanism: a two-step mendelian randomization study

  2025cites this paper
• Development and Characterization of 3-Dimensional Cell Culture Models of Adrenocortical Carcinoma

  2024cites this paper
• The Role of Inositols in Endocrine and Neuroendocrine Tumors

  2024cites this paper
• Age-related biological differences in children’s and adolescents’ very rare tumors

  2023cites this paper
• Preclinical Models of Adrenocortical Cancer

  2023cites this paper
• Sensitivity of the Neuroendocrine Stress Axis in Metabolic Diseases

  2023cites this paper
• High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study

  2023cites this paper
• miRNAs orchestration of adrenocortical carcinoma - Particular emphasis on diagnosis, progression and drug resistance.

  2023cites this paper
• Pathophysiological Link between Insulin Resistance and Adrenal Incidentalomas

  2022cites this paper
• Retrospective Analysis of Prognostic Factors in Pediatric Patients with Adrenocortical Tumor from Unique Tertiary Center with Long-Term Follow-Up

  2022cites this paper
• Histopathological Criteria for Paediatric Adrenocortical Carcinoma

  2022cites this paper
• Whole Transcriptome Profiling of Adrenocortical Tumors Using Formalin-Fixed Paraffin-Embedded Samples

  2022cites this paper
• Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer

  2022cites this paper
• Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies.

  2022cites this paper
• Adrenocortical Carcinoma in Childhood: A Systematic Review

  2021cites this paper
• Mitotane treatment in adrenocortical carcinoma: mechanisms of action and predictive markers of response to therapy.

  2021cites this paper
• SIRT1 is involved in adrenocortical cancer growth and motility

  2021cites this paper
• Upregulation of TCF21 inhibits migration of adrenocortical carcinoma cells

  2021cites this paper
• Upregulation of TCF21 Inhibits Migration of Adrenocortical Carcinoma Cells

  2021cites this paper
• Primary Cultures and Cell Lines for In Vitro Modeling of the Human Adrenal Cortex.

  2021cites this paper
• The IGF2 methylation score for adrenocortical cancer: an ENSAT validation study.

  2020cites this paper
• Pediatric adrenocortical tumor - review and management update.

  2020cites this paper
• High Prevalence of Alterations in DNA Mismatch Repair Genes of Lynch Syndrome in Pediatric Patients with Adrenocortical Tumors Carrying a Germline Mutation on TP53

  2020cites this paper
• Non-Coding RNAs in Adrenocortical Cancer: From Pathogenesis to Diagnosis

  2020cites this paper
• Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management

  2020cites this paper
• Medical management of adrenocortical carcinoma: current recommendations, new therapeutic options and future perspectives.

  2020cites this paper
• LONG-TERM FOLLOW UP AND TREATMENT OUTCOMES OF A 2 YEAR-OLD-BOY WITH METASTATIC TESTOSTERONE-SECRETING ADRENOCORTICAL CARCINOMA.

  2020cites this paper
• New Prognostic Indicators in Pediatric Adrenal Tumors: Neuroblastoma and Adrenal Cortical Tumors, Can We Predict When These Will Behave Badly?

  2020cites this paper
• The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells.

  2020cites this paper
• Next-generation therapies for adrenocortical carcinoma.

  2020cites this paper
• MicroRNA dysregulation interplay with childhood abdominal tumors

  2019influential citation
• The role of mTOR pathway as target for treatment in adrenocortical cancer

  2019cites this paper
• Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures

  2019cites this paper
• A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

  2019cites this paper
• IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer

  2019cites this paper
• Insulin resistance and adrenal incidentalomas: A bidirectional relationship.

  2019cites this paper
• Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours

  2019cites this paper
• Hsp90 inhibition in adrenocortical carcinoma: Limited drug synergism with mitotane.

  2019cites this paper
• The role of epithelial growth factors and insulin growth factors in the adrenal neoplasms.

  2018cites this paper
• European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors.

  2018cites this paper
• The human adrenal cortex: growth control and disorders

  2018cites this paper
• The role of insulin-like growth factor system in the adrenocortical tumors.

  2018cites this paper
• Efficacy of oral metformin in a patient with metastatic adrenocortical carcinoma: Examination of mechanisms and therapeutic implications

  2018cites this paper
• Elucidating the Role of the Maternal Embryonic Leucine Zipper Kinase in Adrenocortical Carcinoma

  2018cites this paper
• Methylation status of Vitamin D receptor gene promoter in adrenocortical carcinoma

  2018cites this paper
• The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells

  2018cites this paper
• Update on adrenocortical carcinoma management and future directions

  2017cites this paper
• New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells

  2017cites this paper
• Genetics of Adrenocortical Cancers

  2017cites this paper
• Management of Adrenal Masses in Children and Adults

  2017cites this paper
• GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior

  2017cites this paper
• Genetics of tumors of the adrenal cortex.

  2017cites this paper
• Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma

  2017cites this paper
• Pediatric adrenal cortical carcinomas: Histopathological criteria and clinical trials. A systematic review.

  2016cites this paper
• Effects of Type 1 Insulin-Like Growth Factor Receptor Silencing in a Human Adrenocortical Cell Line

  2016cites this paper
• Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas.

  2016cites this paper
• The challenge of developmental therapeutics for adrenocortical carcinoma

  2016cites this paper
• Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma

  2016cites this paper
• Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.

  2016cites this paper
• 5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications

  2016cites this paper
• Adrenocortical tumors and insulin resistance: What is the first step?

  2016cites this paper
• Unraveling the expression of the oncogene YAP1, a Wnt/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients

  2016cites this paper
• Insulin‐Like Growth Factor—Phosphatidylinositol 3 Kinase Signaling in Canine Cortisol‐Secreting Adrenocortical Tumors

  2015cites this paper
• The effect of chronic preconception paternal alcohol intake on sperm methylation signatures and subsequent gene expression in mouse offspring

  2015cites this paper
• The genetics of adrenocortical tumors.

  2015cites this paper
• Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma

  2015cites this paper
• Clinical, Magnetic Resonance Imaging, and Histopathologic Findings in 6 Dogs with Surgically resected Extraparenchymal Spinal Cord Hematomas

  2015cites this paper
• Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis

  2015cites this paper
• Molecular pathways of human adrenocortical carcinoma - translating cell signalling knowledge into diagnostic and treatment options.

  2015cites this paper
• Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer

  2015cites this paper
• Análise da expressão e do silenciamento do receptor tipo 1 do fator de crescimento semelhante à insulina em tumores adrenocorticais humanos

  2015cites this paper
• Development of adrenal cortex zonation.

  2015cites this paper
• IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis.

  2015cites this paper
• DAX1 Overexpression in Pediatric Adrenocortical Tumors: A Synergic Role with SF1 in Tumorigenesis

  2015cites this paper
• Pediatric Adrenocortical Tumors: What They Can Tell Us on Adrenal Development and Comparison with Adult Adrenal Tumors

  2015cites this paper
• Adrenocortical cancer (ACC) - literature overview and own experience.

  2015cites this paper
• Genetics of Adrenal Tumors

  2014cites this paper
• MicroRNA Era: The Importance for Diagnosis and Prognosis of Adrenocortical Tumors

  2014cites this paper
• IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma

  2014cites this paper
• The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial

  2014cites this paper
• Molecular markers and targeted therapies for adrenocortical carcinoma

  2014cites this paper
• Genetics and epigenetics of adrenocortical tumors.

  2014cites this paper
• Amplification of the Insulin-Like Growth Factor 1 Receptor Gene Is a Rare Event in Adrenocortical Adenocarcinomas: Searching for Potential Mechanisms of Overexpression

  2014cites this paper
• Analysis of IGF and IGFBP as Prognostic Serum Biomarkers for Adrenocortical Carcinoma

  2014cites this paper
• Withanolides are Potent Novel Targeted Therapeutic Agents Against Adrenocortical Carcinomas

  2014cites this paper
• Sonic hedgehog signaling is active in human adrenal cortex development and deregulated in adrenocortical tumors.

  2014cites this paper
• Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.

  2014cites this paper
• Roles of the Pathologist in Evaluating Surrogate Markers for Medical Therapy in Adrenocortical Carcinoma

  2014cites this paper
• Pediatric adrenocortical tumors: diagnosis, management and advancements in the understanding of the genetic basis and therapeutic implications

  2014cites this paper
• Análise da viabilidade das células H295R, linhagem de carcinoma adrenocortical tumoral humano, tratadas com diferentes drogas antitumorais

  2014cites this paper
• O PAPEL DO FATOR DE TRANSCRIÇÃO POD-1 NA REGULAÇÃO DE SF-1 E LRH-1 EM CÉLULAS TUMORAIS DA SUPRARRENAL HUMANA

  2014cites this paper
• Caracterização molecular e funcional de células de tumores adrenocorticais humanos.

  2014influential citation
• Adrenocortical carcinoma.

  2014cites this paper
• Conventional chemotherapy and emerging targeted therapy for advanced adrenocortical carcinoma.

  2013cites this paper
• Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma

  2013cites this paper
• Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane.

  2013cites this paper